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Background: Annual community-directed treatment with ivermectin (CDTI) have been carried out since 1999 in
the Lekie division (central region of Cameroon where most cases of Loa-related post ivermectin severe adverse
events were reported) as part of the joined activities of the African Programme for Onchocerciasis Control (APOC)
and Mectizan® Donation Program (MDP). As large-scale administration of ivermetine was demonstrated to be an
efficient means to control loiasis transmission, it was hypothesized that CDTI would have lowered or halted the
transmission of Loa loa in the Lekie division after 13 years of annual drug administration, indicating a possible
reduction in the occurrence of Loa-related post-ivermectin severe adverse events.
Methods: A 4-month entomologic study was carried out from March to June 2012 in the Lekie division to evaluate
the impact of 13 years of CDTI on the transmission of L. loa whose baseline data were recorded in 1999–2000.
Results: There was a significant reduction in the infection rate for Chrysops silacea and C. dimidiata from 6.8 and
9% in 1999–2000 to 3 and 3.6% in 2012, respectively. The differences in the infective rate (IR) (percentage of flies
harboring head L3 larvae), potential infective rate (PIR) (percentage of flies bearing L3 larvae), mean head L3 larvae
load (MHL3) (average L3 per infective fly) and mean fly L3 larvae load (MFL3) (average L3 per potentially infective
fly) for both C. silacea and C. dimidiata were not significantly different between the two investigation periods. The
biting density (BD) was almost three-fold higher in 2012 for C. silacea but not for C. dimidiata. The transmission
potential (TP) which is a function of the BD, was higher in the present study than in the baseline investigation
for each species.
Conclusion: The infection rate remaining high, the high TP and the stability observed in the IR, PIR, MHL3 and
MFL3 after 13 years of CDTI suggest that transmission of L. loa is still active. This is an indication that the risk of
occurrence of severe adverse events such as fatal encephalopathies is still present, especially for heavily
microfilaria-loaded people taken ivermectin for the first time.
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Control programs against onchocerciasis and lymphatic
filariasis are based on mass treatment with ivermectin
(IVM) and a combination of IVM and albendazole,
respectively. Since 1991, serious adverse events (SAEs),
including fatal cases of encephalopathy have been
recorded in areas where onchocerciasis and loiasis (Loa
loa filariasis) are co-endemic. In the following years, it
has been shown that these accidents occur in individuals
presenting a L. loa microfilaremia exceeding 30,000
microfilariae per milliliter of blood (mf/ml) [1-4]. L. loa
is transmitted by tabanids belonging to the genus
Chrysops and is highly endemic in forested regions as
well as in some savanna areas of west and central Africa
[5,6]. In 2000, the African Programme for Onchocer-
ciasis Control (APOC) and the Mectizan® Donation
Program (MDP) set up a specific surveillance system in
areas where onchocerciasis and loiasis are co-endemic,
for an early detection and management of SAEs [7,8].
This strategy has been successful in terms of reduction
of lethality rate, but is somewhat costly to put in place
[9]. Thus, the issue has been raised as to whether it
should be maintained for as long as the community-
directed treatment with IVM (CDTI) continues. Indeed,
as IVM brings about a long-lasting decrease in Loa
microfilaremia [10,11], almost all those individuals who
have received the drug at least once are no longer at risk
of developing a SAE. This is supported by the fact that
more than 90% of the SAEs occur after a first treatment
with IVM [12]. During the subsequent CDTIs, the
surveillance system has to be maintained to detect and
manage SAEs only in those adults who have never taken
the drug for various reasons (refusals, migrants from un-
treated areas, repeated contra-indications) and in all
children reaching the age of 5 for whom IVM was
formerly contra-indicated. Maintaining the system is
justified by the fact that during the first rounds of CDTI,
the situation of these untreated persons regarding their
infection with L. loa remains probably unchanged. How-
ever, on a longer term, this is probably not the case
because the decrease in the microfilarial reservoir
following mass IVM treatment might also reduce the
number of parasites ingested and retransmitted by the
vectors, and thus have a beneficial indirect effect on the
total population, including those who have never taken
the drug. Actually, this reduction in the transmission of
L. loa in the CDTI area would have two effects. First, in
uninfected or little infected children the reduction in the
number of incoming infective larvae (L3) would have an
impact on the number of adult worms developing, which
might prevent them to present a high microfilaremia.
Second, in adult subjects who already harbour adult
worms, and do not receive the drug, it would lead to a
slow reduction in the microfilaremia due to the fact thatthe number of worms dying naturally would exceed the
number of new parasites. However, in the latter case, the
time after which this effect would occur is not known
because one lacks information on the mean lifespan of
adult L. loa - the only information available is on its
maximum, which could be 20 years [13].
The objective of the present study was to evaluate the
impact of repeated annual IVM treatment on the inten-
sity of transmission of loiasis, and thus on the possible
reduction in the risk of SAEs in the untreated popu-
lation. Such an evaluation can be made by two means:
either by comparing the microfilarial loads found in
untreated children before and after the implementation
of the program, as it has been done for onchocerciasis
[14], or by comparing the intensity of infection in the
Chrysops vectors. Such an entomologic approach has
been used to evaluate the impact of three monthly treat-
ments on Loa transmission [15], but never that of
annual CDTI. Consequently, an entomologic study was
conducted in a village of the Lekie division (a division of
the central region of Cameroon where most of the cases
of SAEs recorded in the country occurred) where the
transmission of loiasis had been characterized in detail
in 1999–2000 at the early beginning of CDTI.
Methods
Study area
This site (Figure 1) was already described in detail by
Demanou et al. [16]. Brievely, Kokodo (4°12’N, 11°18’E)
is located in the Elig Mfomo subdivision, about 70 km
north-west of Yaounde, in an area of semi-degraded for-
est. Elig Mfomo is within the Lekie division where most
cases of SAEs have been documented [4,16]. The climate
is equatorial with four seasons comprising two rainy
seasons from September to mid-November, and from
mid-March to June. The annual rainfall ranges between
1600 and 2000 mm, and the mean annual temperature is
25°C. In 2010, the total population in Kokodo was 1615
persons.
No survey on onchocerciasis has ever been conducted
in Kokodo. However, the parasitologic surveys and rapid
epidemiologic assessments (based on the prevalence of
nodules) performed in the 1990s in neighboring villages,
have shown that the area is at least mesoendemic for
onchocerciasis (Boussinesq, unpublished data).
Previous studies on loiasis in Kokodo
In January 1996, the village was included in a study
aiming at identifying the risk factors associated with
post-IVM SAEs [4]. Detailed data on Kokodo currently
presented, though part of the study by Gardon et al. [4]
in the Lekie division, were not previously published. A
total of 453 persons aged 15 years and above partici-
pated in the study. All individuals were first asked
Figure 1 Map of Kokodo, with location of capture points (adapted from [16], with author’s permission).
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107 (23.6%) declared they had so (3 in 1993, 72 in 1994
and 32 in 1995). This relatively high proportion of
persons already treated was due to the fact that large-
scale IVM treatments were organized since 1993 by the
Ministry of Public Health and the non-governmental
development organization (NGDO) Helen Keller Inter-
national (HKI) in the neighboring sub-division of
Monatele. After having been registered, all those persons
aged 15 years and above and who had never taken IVM
(N = 69) were invited to provide blood by fingerprick to
prepare blood smears to assess the prevalence and inten-
sity of Loa microfilaremia. All the 453 volunteers
received a single dose of IVM (150 μg/kg) just after
sampling. Subsequent examination of the blood smears
showed that the prevalence of Loa microfilaremia in the
69 ivermectin-naïve adults was 29.0% and the arithmetic
mean microfilarial density among the microfilaremics
was 10,401 mf/ml.
In 1999, a second study was implemented in Kokodo
whose objectives were (i) to characterize the transmis-
sion of L. loa by examining Chrysops caught over 12
months (May 1999-April 2000) in various places of the
village [16] and (ii) to identify individual factors associ-
ated with the presence of Loa microfilaremia [17]. For
the second part of the study, all residents aged ≥ 15 years
were again invited to be examined for Loa infection in
April 1999, just before the first CDTI campaign launched
by APOC in the area. Among the 441 who volunteered,141 (32.0%) declared they had received IVM after the
1996 study. The prevalence of Loa microfilaremia among
the adults aged ≥15 years who had not received IVM
between 1996 and 1999 was 29.0% (like in 1996) and the
arithmetic mean microfilarial density among the micro-
filaremics was 8861 mf/ml.
Ivermectin treatment in Kokodo
As mentioned above, Kokodo is not far from the border
with the Monatele sub-division where large-scale IVM
treatments have been organized from 1993 to 1998 by
the Ministry of Public Health and HKI. Thus, a number
of persons living in Kokodo could receive treatment
during this period. Since 1999, Kokodo has been treated
annually under the auspices of APOC, following the
CDTI strategy. Drug coverages in the village itself are
unknown for the years 1999–2006 but figures on the
whole CDTI project (“Centre 3”) were available for this
period. For the years 2007–2010, coverage data on the
village of Kokodo could be provided by the National
Program for Onchocerciasis Control and HKI.
Catches and dissection of Chrysops in 2012
Catches were organized from 1 March to 30 June 2012,
in exactly the same sites and conditions as in the first
entomologic study [16]. This four-month period was
chosen because it started and ended 6 and 10 months
respectively, after the end of the previous CDTI
campaign (August 2011). The captures were conducted
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(forest, cacao farms, crop fields, mixed crop fields and
inhabited areas). Two catching stations were chosen for
each of these types, and catches of Chrysops were made
every two weeks during three consecutive days. In this
paper, data for all habitats were pooled for each study
period. Flies were caught using hand nets from 07:00 to
18:00 by collectors stationed by a wood fire, the smoke
of which attracts the flies [18,19]. One collector was
allowed to catch between 7:00 and 12:00 and another
one took over from 12:00 to 18:00. Each collector was
rotated to a different caching station every day. The flies
caught were put singly in a glass tube plugged with a
cotton wool and grouped in bags labeled according to
the catching station, environment type and hour. Bags
were collected every two hours and brought back to the
field laboratory where flies were first identified, then
dissected alive after a slight knock down using a needle
tip, and examined for parity and presence of L. loa
larvae (first stage L1, second stage L2, and third stage L3
larvae). Dissection was carried out by a single individual.
Identification of larvae was performed following the
method of Orihel and Lowrie [20].
The head, thorax and abdomen were dissected separ-
ately. The infection rate was defined as the proportion
of flies containing any larval stage (L1, L2 or L3), and
the infective rate (IR) as the proportion of flies with L3s
in the head or mouth parts. The potential infective rate
(PIR) was considered as the proportion of dissected flies
with L3 larvae, irrespective of their location in the fly.
The infection and infective rates have been calculated
using, first, the total number of flies, and then the num-
ber of parous flies, as the denominator. The mean head
L3 load (MHL3) corresponded to the total number of
L3s found in the head and mouth parts divided by the
total number of Chrysops carrying L3s in this location.
The mean fly L3 load (MFL3) was determined as the
total number of flies with L3 larvae divided by the total
number of flies with these larvae. The monthly transmis-
sion potential (MTP) was expressed as the number ofTable 1 Entomologic indices at baseline study (1999–2000)
Study
period
No. of chrysops caught* BD T
S D S+D S D S+D S D
March 63 10 73 32.6 5.2 37.8 55.6 0
April 251 56 307 125.5 28.0 153.5 754.9 9
May 184 41 225 47.5 10.6 58.1 12.4 0
June 339 38 377 78.2 8.8 87.0 95.1 4
Total 837 145 982 283.8 52.6 336.4 918 1
p-value - - - -
*All the Chrysops were dissected except six C. silacea caught in March (2) and April
load; S= Chrysops silacea; D= Chrysops dimidiata; S+D= both species combined.infective larvae per man per month (L3/man/month),
while the monthly biting density (MBD) was estimated
as the mean number of fly bites per person per month
(bites/man/month). The calculations of MBD and MTP
were made using the formula used as part of studies on
onchocerciasis transmission [21].
Statistical analyses
As mentioned above, the first entomologic study was
conducted over 12 months, i.e. between 1 May 1999 and
30 April 2000. As the indicators of interest in this study
(infection rate, IR, PIR, MHL3 and MFL3) fluctuate
seasonally [16,22-24], we decided to compare the figures
obtained in 2012 with those obtained during the same
months in 1999 and 2000 (March and April 2000, and
May and June 1999). The non parametric Wilcoxon rank
two-sample test was used to compare the MHL3 and
MFL3 between 1999–2000 and 2012. Chi-square test
was used to compare the infection rates, IR and PIR
between the two periods. These comparisons were done
on the infection and infective rates in the total number of
Chrysops, and then on the rates in the parous flies only.
Fischer’s exact test was used in place of Chi-square test
whenever the expected value was less than 5. The signi-
ficance level was set at 0.05 in all cases. All statistical
analyses were performed using the STATA 12.1 software
(STATA Corporation, College Station, TX, USA).
Results
Entomologic indices
During the initial study, the total numbers of Chrysops
caught during the 4 month-period (March and April
2000, May and June 1999) was 982, and 976 of them
were dissected (Table 1). C. silacea accounted for 85.2%
of catches (14.8% for C. dimidiata). The infection and
infective rates did not differ significantly between both
species (p = 0.94 and 0.89, respectively). The MHL3 was
higher for C. silacea than for C. dimidiata but due to
the low number of infective C. dimidiata, the signifi-
cance in the difference could not be computed. Of theP Infection rate (%) Infective rate (%) MHL3 load
S+D S D S+D S D S+D S D S+D
.0 55.6 3.6 20.0 6.2 3.6 0.0 3.1 53.5 0.0 53.5
.0 763.9 9.3 12.5 9.9 3.6 3.6 3.6 162.5 9.0 134.5
.0 12.4 7.0 0.0 5.8 1.6 0.0 1.3 16.0 0.0 16.0
.6 99.7 5.3 10.5 5.8 0.9 2.6 1.1 137.4 20.0 108
3.6 931.6 6.7 9.0 7.1 2.1 2.1 2.1 119.4 12.7 103.4
0.94 - 0.89 -
(4); BD= biting densities; TP= transmission potential; MHL3= mean head L3
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and 4 C. dimidiata). The PIR was 2.8% for each of the
two species. The MFL3 was 123 L3/fly for both species
combined, and 141 and 18 L3/fly for C. silacea and C.
dimidiata respectively.
Between March and June 2012, a total of 1559
Chrysops was caught and 1558 were dissected (Table 2).
As previously observed in the baseline study, C. silacea
was found to predominate, with a proportion of 92.9%
of the Chrysops caught. Like in 1999–2000, the infection
and infective rates were quite similar between both
species (p = 0.94 and 0.89, respectively) and the MHL3
was higher in C. silacea than in C. dimidiata (again, the
significance of the difference could not be computed
due to the low number of infective C. dimidiata). Of the
1558 flies dissected, 33 (2%) carried L3s (30 C. silacea
and 3 C. dimidiata). The PIR were 2.0% and 2.8% for C.
silacea and C. dimidiata respectively. The MFL3 were
122 and 121 L3/fly for C. silacea and C. dimidiata
respectively, and 121 L3/fly for both species combined.Comparison of the entomologic indicators recorded in
1999–2000 and in 2012
Results of comparisons are presented in Table 3. In the
initial study, the infection and infective rates of C.
silacea during the four months were 6.7 and 2.1%,
respectively, whereas in 2012, the same indicators for
this species were 3.0% and 1.7% respectively. The infec-
tion rate for this species was significantly lower in 2012
than in 1999–2000 (p = 0.001). In contrast, the infective
rates recorded during the two periods for this species
did not differ significantly (p = 0.49). Similarly, the infec-
tion rate was significantly lower for C. dimidiata in 2012
than in the baseline study (p = 0.04) while no significant
difference in the IR for this species was reported
between the two periods of investigation (p = 0.73).
Considering both species pooled together, the infection
rate in 2012 (3.0%) was significantly lower than in the
baseline study (7.1%) (p = 0.001), while the infective rateTable 2 Entomologic indices in the present investigation (201
Study
period
No of chrysops caught* BD
S D S+D S D S+D S D
March 282 42 324 213.9 39.3 253.2 572.5 0
April 270 31 301 136.0 17.0 153.0 204.6 0
May 584 26 610 303.8 15.5 319.3 30.2 1
June 313 11 324 157.0 7.0 164.0 352.0 0
Total 1449 110 1559 810.5 78.8 889.5 1159.3 1
p-value - - -
*All the Chrysops were dissected except one C. silacea caught in March; BD= biting
silacea; D= Chrysops dimidiata; S+D= both species combined.(1.7% in 2012 and 2.1% in initial study) was not
(p = 0.55).
The PIRs recorded in the 2012 study were not signifi-
cantly different from that recorded in 1999–2000 and
this holds true either for C. silacea alone, or C dimidiata
alone, or both species combined (p = 0.29, 0.99 and 0.30
respectively).
There was no significant difference in the MHL3
between the two investigation periods for C. silacea
(p = 0.91), C. dimidiata (p = 0.51), and both species
combined (p = 0.91). Similarly, the difference in the
MFL3 between the two studies was not significant for
C. silacea (p = 0.84), C. dimidiata (p = 0.48) or both
species pooled together (p = 0.55).
The biting density was almost three-fold higher in
2012 than in 1999–2000 for C. silacea but remained
stable for C. dimidiata.
The transmission potential was higher in the present
study than in the baseline investigation for each species
or both species combined. There was a monthly vari-
ation in the transmission potential during both investi-
gation periods (Tables 1 and 2).
The parous rate (Table 4) was significantly higher
in the initial survey than in the second for C. silacea
(p = 0.00007) and both species combined (p = 0.00001). As
in the total Chrysops population dissected, there was a
significant decrease in the infection rate for C. silacea and
both species combined in parous fly population, from 19.4
and 20.1% respectively in the initial study to 11.1% in the
present study (p = 0.002 and 0.0005 respectively). Also,
the infective and potential infective rates between the two
periods for each species and for both species combined
were not significantly different in parous flies.Drug coverage
The drug coverages in the whole CDTI project area were
46% in 1999, 29% in 2000, 29% in 2001, 50% in 2002,
62% in 2003, 67% in 2004, 64% in 2005, and 79% in
2006. For the following years, data was available at the2)
TP Infection rate (%) Infective rate (%) MHL3 load
S+D S D S+D S D S+D S D S+D
.0 572.5 3.9 2.4 3.7 2.5 0.0 2.2 100.7 0.0 100.7
.0 204.6 3.3 0.0 3.0 2.2 0.0 2.0 67.7 0.0 67.7
7.3 47.5 2.1 11.5 2.5 0.9 11.5 1.3 11.6 9.7 10.9
.0 352.0 3.5 0.0 3.4 1.9 0.0 1.9 117.3 0.0 117.3
7.3 1176.6 3.0 3.6 3.0 1.7 2.7 1.7 78.0 9.7 70.0
0.94 0.89 -
densities; TP= transmission potential; MHL3= mean head L3 load. S= Chrysops
Table 3 Comparison of entomological indices between the two study periods (baseline study (1999–2000) and present
investigation)
Study period Infection rate (%) Infective rate (%) Potential infective rate MHL3 load MFL3 load
S D S+ D S D S+ D S D S+D S D S+ D S D S+D
Baseline 6.7 9.0 7.1 2.1 2.1 2.1 2.8 2.8 2.8 119.0 13.0 103.0 141.0 18.0 123.0
2012 3.0 3.6 3.0 1.7 2.7 1.7 2.0 2.8 2.0 78.0 10.0 70.0 122.0 121.0 121.0
p-value 0.001 0.04 0.001 0.49 0.73 0.55 0.29 0.99 0.30 0.91 0.51 0.91 0.84 0.48 0.55
NB: S= Chrysops silacea; D= Chrysops dimidiata; S+D= both species combined; MHL3= mean head L3 load; MFL3= mean fly L3 load.
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ranged from 67.9% in 2007 to 80.2% in 2010, with values
of 79.5% and 79.9% in 2008 and 2009, respectively. Data
related to 2011 were not available at the time of study.
Discussion
As in the initial study by Demanou and others [16], C.
silacea and C. dimidiata were the only species caught
during the investigation period, C. silacea being the
predominating species. Previous studies showed that C.
silacea was the dominating species in all Loa endemic
areas in Cameroon except in the village of Ngat, 50 km
south of Yaounde where C. dimidiata is the main vector
of loiasis [15]. Our study confirmed that C. silacea is the
most important vector in the Lekie area, both because of
higher MHL3 (7.5- fold higher than in C. dimidiata),
and of higher biting densities (10.3- fold higher than
C. dimidiata biting densities).
IVM is an effective drug against O. volvulus, L. loa,
Wuchereria bancrofti and is currently recommended and
used by different global programs for the control of
onchocerciasis and lymphatic filariasis. Regarding loiasis
specifically, several studies showed that a single dose of
IVM brings about a marked and long-standing decrease
in Loa microfilaremia, lowers the prevalence of loiasis
[10,11], and reduces the infective rate of the Chrysops to
low levels when given on a large scale at 3-monthly
intervals [15]. Since large-scale administration of IVM
was demonstrated to be an efficient means to control
Loa transmission, it was hypothesized that CDTI would
have had such a result in the Lekie division after several









S D S+D S D S+D S
Baseline 831 145 976 289 55 344 34.5
2012 1448 110 1558 389 34 423 26.9
p-value 0.00007
NB: S= Chrysops silacea; D= Chrysops dimidiata; S+D= both species combined.in this division, entomologic data on the transmission of
loiasis were recorded over 1 year, and distribution of
IVM has been conducted annually, every year, with vari-
ous therapeutic coverage rates. To evaluate the impact
of this drug coverage on the transmission of loiasis,
entomologic data were collected over a 4-month period
from March to June 2012 and compared with the
baseline data.
In 2012, the biting densities for C. silacea and C.
dimidiata were 811 and 79 bites/man respectively for a
4- month study period, while for the same months and
study duration in 1999–2000, these values were almost
three-fold lower for C. silacea and nearly similar for C.
dimidiata. Both species were shown to be sensitive to
rainfall, but with a dominion of C. silacea over C.
dimidiata in the rainy season [23]. The increase in the
density of C. silacea but not C. dimidiata might be
related to an increase in the rainfall in this area.
In the present study, we have used a number of indica-
tors to evaluate the impact of CDTI on Loa transmis-
sion. As the infective forms of L. loa were suspected to
be able to pass freely and fast from the head to the
abdomen or vice-versa when the fly is feeding [25], flies
carrying L3s were considered both when the latter were
located in their head, or in other locations (thorax or
abdomen). In spite of the significant reduction in Loa
infection rate for each species (C. silacea and C.
dimidiata) observed in 2012, the values of the IR, PIR,
MHL3 and MFL3 recorded in 2012 were not signifi-
cantly different from the initial values obtained in the
baseline investigation for each species. The results were









D S+D S D S+D S D S+D S D S+D
37.9 35.2 19.4 23.1 20.1 5.9 5.5 5.8 8 7.3 7.8
30.9 27.2 11.1 11.8 11.1 6.2 8.8 6.4 7.7 8.8 7.8
0.24 0.00001 0.002 0.16 0.0005 0.87 0.53 0.74 0.90 0.79 0.98
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in the values of these indices indicates that the level of
exposure of L. loa has not changed after 13 years of
treatment. Moreover, the intensity of infection remained
high despite the significant drop observed in the infec-
tion rate. These surprising and disappointing observa-
tions could be attributed to several facts, some of which
are: 1) the persistence of a significant parasite reservoir;
2) an increase in the density of vector flies; 3) the biting
habits of the vector flies.
The parasite reservoirs are the microfilaria carriers,
including the fraction of the population that remains
untreated [26]. Among these individuals, some refuse to
be treated by fear of SAEs. In this respect, it is worth
noticing that in the past, the Lekie division had expe-
rienced many cases of SAEs [27]. In spite of the proper
sensitization of populations through explanations of the
advantages of taking IVM, reassurance about efficacy
and safety about availability in health facilities of kits to
manage possible SAE cases, some people are still reluc-
tant to comply with the program. Other individuals who
can act as reservoir are infected immigrants or former
residents returning to the village from towns or areas
where there is not treatment. A third group consists of
residents remaining untreated due to shortage of drug
during the CDTI campaign. Indeed, complaints on this
issue were recorded by our team more than once in the
field during Chrysops collection.
A second reason which may partly explain the limited
impact of CDTI on entomologic indicators on Loa
transmission is the increase in the density of Chrysops
between 2000 and 2012. Whatever the reason(s) for this
increase, this phenomenon increases the likelihood of a
vector to bite an infected person and to pass on sub-
sequently the infection to others, including healthy
individuals.
Lastly, the biting behavior of Chrysops known as pool-
feeding is very painful to the host. As a result, the fly
usually bites multiple hosts in order to feed to repletion.
This habit of multiplying the blood source increases the
probability for the fly to feed on microfilaria carriers.
The fact that the infection rate was significantly
reduced while the IR, PIR, MHL3 and MFL3 were not
may be related to the reduction of parasite reservoir
among the treated population for the first case, and to a
phenomenon of “limitation” (where the parasite ‘success
rate’ or ‘yield’ in the vector increases as the mf intake
decreases) for the latter case. The parasite yield is high
with Chrysops, as observed by Kershaw and Duke [28],
and this might be due to the ability of Chrysops to live
normally even when they harbor very high numbers of
L3 [28,29]. However, there is little information on the
type of relationships (limitation, facilitation or propor-
tionality) between the number of Loa mf ingested by theChrysops and the number of infective larvae. This is due
to the fact that, the Chrysops bites being painful, it is dif-
ficult to infect experimentally these vectors by making
them feed on humans. However, Kershaw and Duke [28]
found that “the number of infective forms found in flies
which survive long enough to support the development of
the infective forms is similar to the number of microfilariae
taken in”, suggesting the relationship is proportional. This
does not explain the results obtained during the present
study and should encourage conducting studies on this
issue. Chrysops could be fed with blood from naturally
infected human or from experimentally-infected baboons;
in the latter case, blood meal could be taken directly on
the host but in both cases, feeding could be made using a
parafilm membrane technique [30].
In addition to these main facts, the therapeutic cover-
age as well as the duration of the treatment campaign
within a year needs to be addressed. The official drug
coverage from 2007 to 2010 ranged between 67.9 to
80.2%. With such fairly high coverages, one might have
expected a significant reduction in the transmission level
of loiasis after more than a decade of drug administration,
not a standstill [31]. Therefore, another explanation to the
stability in the indicators might be that the therapeutic
coverage reported might be overrated. External assess-
ment of therapeutic coverage should be encouraged to
validate or revise official figures. Since onchocerciasis and
loiasis are co-endemic in the study area, and the parasite
reservoir (human population) is the same for both O. vol-
vulus and L. loa, the stability in the transmission level of
loiasis despite several years of CDTI might also be found
for onchocerciasis. This is supported by the results of
recent epidemiological investigations on onchocerciasis in
the neighboring health district Mbam valley, which
showed that some villages still had very high prevalences
of O. volvulus infection (>50%) in spite of 15 rounds of
annual CDTI (Boussinesq et al., unpublished data). The
authorities in charge of onchocerciasis control program
should consider the results of the present investigation for
the better management of their activities in that area.
Also, epidemiological studies on L. loa transmission in the
Lekie division are necessary to complement this work.
Conclusion
In conclusion, this study showed that the transmission
of loiasis in the Lekie division is still active, as suggested
by the infection rate remaining high, the high TP and
the stability observed in the IR, PIR, MHL3 and MFL3
after 13 years of CDTI. This is an indication that the risk
of occurrence of severe adverse events such as fatal
encephalopathies is still present, especially for heavily
microfilaria-loaded people taken ivermectin for the first
time. Complementary data on the level of Loa microfila-
remia are needed in the area.
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